Literature DB >> 18373180

Locoregional control remains a critical issue in gastric cancer.

Jolie Ringash, Stephen R Smalley, Leonard L Gunderson.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18373180     DOI： 10.1007/s10120-008-0454-y

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  10 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.

Authors:  Zahra Kassam; Gina Lockwood; Catherine O'brien; James Brierley; Carol Swallow; Amit Oza; Lillian Siu; Jennifer J Knox; Rebecca Wong; Bernard Cummings; John Kim; Malcolm Moore; Jolie Ringash
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-19       Impact factor: 7.038

3.  Improved regional control and survival with "low Maruyama Index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial.

Authors:  Scott A Hundahl; Koen C M J Peeters; E Klein Kranenbarg; Henk Hartgrink; Cornelis J H van de Velde
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

4.  Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

5.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

6.  Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.

Authors:  Scott A Hundahl; John S Macdonald; Jacqueline Benedetti; Thomas Fitzsimmons
Journal:  Ann Surg Oncol       Date:  2002-04       Impact factor: 5.344

Review 7.  Gastric cancer--patterns of relapse after surgical resection.

Authors:  Leonard L Gunderson
Journal:  Semin Radiat Oncol       Date:  2002-04       Impact factor: 5.934

8.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

9.  Adjuvant therapy for resected gastric cancer--rapid, yet incomplete adoption following results of intergroup 0116 trial.

Authors:  Natalie G Coburn; Ulrich Guller; Nancy N Baxter; Alex Kiss; Jolie Ringash; Carol J Swallow; Calvin H L Law
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-01       Impact factor: 7.038

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.